Verastem Stock Performance

VSTM Stock  USD 6.22  0.16  2.51%   
The entity has a beta of -0.0179, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Verastem are expected to decrease at a much lower rate. During the bear market, Verastem is likely to outperform the market. At this point, Verastem has a negative expected return of -0.39%. Please make sure to validate Verastem's value at risk, rate of daily change, as well as the relationship between the Rate Of Daily Change and relative strength index , to decide if Verastem performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Verastem has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in February 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more

Actual Historical Performance (%)

One Day Return
(4.63)
Five Day Return
(3.63)
Year To Date Return
(11.76)
Ten Year Return
(61.75)
All Time Return
(95.21)
Last Split Factor
1:12
Last Split Date
2023-06-01
1
Verastem Oncology drops despite Q3 double beat
11/04/2025
2
Verastem Announces Public Offering to Raise 96.9 Million - TipRanks
11/17/2025
3
Disposition of 2000 shares by Paterson Dan of Verastem at 10.0 subject to Rule 16b-3
11/21/2025
4
Disposition of 2000 shares by Paterson Dan of Verastem at 10.32 subject to Rule 16b-3
11/26/2025
5
Verastem Announces Earnings Results
12/03/2025
6
Disposition of 2000 shares by Paterson Dan of Verastem at 10.5 subject to Rule 16b-3
12/08/2025
7
Verastem Oncology announces management changes
12/15/2025
8
Disposition of 283 shares by Gagnon Robert E. of Verastem at 9.14 subject to Rule 16b-3
12/16/2025
9
Disposition of tradable shares by Daniel Calkins of Verastem at 7.86 subject to Rule 16b-3
12/24/2025
10
Verastem stock steady as Mizuho reiterates Outperform rating - Investing.com
12/31/2025
11
Acquisition by Kauffman Michael of 200000 shares of Verastem at 6.88 subject to Rule 16b-3
01/06/2026
12
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635
01/12/2026
13
Daniel Calkins Sells 5,0 Shares of Verastem Stock
01/14/2026
14
Acquisition by Paterson Dan of 213785 shares of Verastem subject to Rule 16b-3
01/21/2026
Begin Period Cash Flow79.1 M
Total Cashflows From Investing Activities60 M

Verastem Relative Risk vs. Return Landscape

If you would invest  885.00  in Verastem on October 28, 2025 and sell it today you would lose (247.00) from holding Verastem or give up 27.91% of portfolio value over 90 days. Verastem is currently does not generate positive expected returns and assumes 5.3744% risk (volatility on return distribution) over the 90 days horizon. In different words, 48% of stocks are less volatile than Verastem, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Verastem is expected to under-perform the market. In addition to that, the company is 7.29 times more volatile than its market benchmark. It trades about -0.07 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Verastem Target Price Odds to finish over Current Price

The tendency of Verastem Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 6.22 90 days 6.22 
roughly 97.0
Based on a normal probability distribution, the odds of Verastem to move above the current price in 90 days from now is roughly 97.0 (This Verastem probability density function shows the probability of Verastem Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Verastem has a beta of -0.0179. This entails as returns on the benchmark increase, returns on holding Verastem are expected to decrease at a much lower rate. During a bear market, however, Verastem is likely to outperform the market. Additionally Verastem has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Verastem Price Density   
       Price  

Predictive Modules for Verastem

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Verastem. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Verastem's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
1.046.3811.72
Details
Intrinsic
Valuation
LowRealHigh
0.666.0011.34
Details
Naive
Forecast
LowNextHigh
0.455.7811.12
Details
9 Analysts
Consensus
LowTargetHigh
14.6716.1217.90
Details

Verastem Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Verastem is not an exception. The market had few large corrections towards the Verastem's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Verastem, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Verastem within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.21
β
Beta against Dow Jones-0.02
σ
Overall volatility
1.21
Ir
Information ratio -0.05

Verastem Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Verastem for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Verastem can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Verastem generated a negative expected return over the last 90 days
Verastem has high historical volatility and very poor performance
Verastem has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 10 M. Net Loss for the year was (130.64 M) with profit before overhead, payroll, taxes, and interest of 11.39 M.
Verastem currently holds about 94.31 M in cash with (104.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5.
Over 87.0% of the company outstanding shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Paterson Dan of 213785 shares of Verastem subject to Rule 16b-3

Verastem Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Verastem Stock often depends not only on the future outlook of the current and potential Verastem's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Verastem's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding35.7 M
Cash And Short Term Investments88.8 M

Verastem Fundamentals Growth

Verastem Stock prices reflect investors' perceptions of the future prospects and financial health of Verastem, and Verastem fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Verastem Stock performance.

About Verastem Performance

By examining Verastem's fundamental ratios, stakeholders can obtain critical insights into Verastem's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Verastem is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 362.32  242.22 
Return On Tangible Assets(1.48)(1.41)
Return On Capital Employed(1.87)(1.78)
Return On Assets(1.48)(1.41)
Return On Equity 5.20  5.46 

Things to note about Verastem performance evaluation

Checking the ongoing alerts about Verastem for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Verastem help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Verastem generated a negative expected return over the last 90 days
Verastem has high historical volatility and very poor performance
Verastem has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 10 M. Net Loss for the year was (130.64 M) with profit before overhead, payroll, taxes, and interest of 11.39 M.
Verastem currently holds about 94.31 M in cash with (104.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5.
Over 87.0% of the company outstanding shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Paterson Dan of 213785 shares of Verastem subject to Rule 16b-3
Evaluating Verastem's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Verastem's stock performance include:
  • Analyzing Verastem's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Verastem's stock is overvalued or undervalued compared to its peers.
  • Examining Verastem's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Verastem's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Verastem's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Verastem's stock. These opinions can provide insight into Verastem's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Verastem's stock performance is not an exact science, and many factors can impact Verastem's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.28)
Revenue Per Share
0.221
Quarterly Revenue Growth
(0.79)
Return On Assets
(0.66)
Return On Equity
(28.89)
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.